تقرير
Pivotal Study to Assess the Efficacy, Safety and Tolerability of Dupilumab in Patients With Moderate to Severe COPD With Type 2 Inflammation (NOTUS)
| العنوان: | Pivotal Study to Assess the Efficacy, Safety and Tolerability of Dupilumab in Patients With Moderate to Severe COPD With Type 2 Inflammation (NOTUS) |
|---|---|
| المؤلفون: | Regeneron Pharmaceuticals |
| المصدر: | A Randomized, Double-blind, Placebo-controlled, Parallel-group, 52-week Pivotal Study to Assess the Efficacy, Safety, and Tolerability of Dupilumab in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD) With Type 2 Inflammation |
| الوصول الحر: | https://clinicaltrials.gov/ct2/show/NCT04456673Test |
| Other URLs: | http://www.copdclinicalstudies.com/?utm_source=ctgovTest |
| قاعدة البيانات: | ClinicalTrials.gov |
| الوصف غير متاح. |